Objective: To identify predictors for achieving a BMI of less than 30 after bariatric surgery.
Background & Aims The effects of bariatric surgery in patients with nonalcoholic fatty liver disease (NASH) are not well established....
We sought to determine the efficacy of high-dose liraglutide (3.0 mg once daily) in patients with prior bariatric surgery.
Non-alcoholic fatty liver disease (NAFLD) is defined by presence of hepatic steatosis (fat accumulation in liver cells), either by imaging...
Purpose of Review: Nonalcoholic steatohepatitis (NASH) is a spectrum of nonalcoholic fatty liver disease (NAFLD). It is defined as the presence of fatty liver along with inflammation and hepatocyte injury. To date, weight loss...
Roux-en-Y Gastric Bypass (RYGB) and Sleeve Gastrectomy (SG) are the most effective therapies for obesity and may have beneficial effects on the immune system. Therefore, we compared RYGB versus SG outcomes in the patients with IBD.
This document is about guidance for commissioning reconstructive procedures, post massive weight loss and is based on the best available evidence.
In this series of articles, we share the epidemiology and current management strategies of NASH as well as the potential for new drug therapies.
The aim of this study was to investigate the effects of a 12-week tailored lifestyle intervention, consisting of physical training and a high protein diet (2 grams/kg), in children with Pompe disease.
Teleflex Incorporated announced it has entered into a definitive agreement to acquire Standard Bariatrics, Inc. which has commercialized an innovative powered stapling technology for bariatric surgery